Pharmacoeconomic review report: Iron isomaltoside 1000 (Monoferric) (Pharmacosmos A/S) indication: for the treatment of iron deficiency anemia in adult patients who have intolerance or unresponsiveness to oral iron therapy

As a bolus injection, up to 500 mg of iron isomaltoside 1000 may be administered up to once weekly at a rate of 250 mg per minute. As an infusion, if the cumulative required iron dose exceeds 20 mg iron/kg body weight, the dose should be split into two administrations given at least a week apart. Si...

Full description

Bibliographic Details

Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) CADTH 2020, May 2020
Edition:	Final
Series:	CADTH common drug review
Subjects:	Disaccharides / Therapeutic Use Adult Canada Ferric Compounds / Economics Anemia, Iron-deficiency / Drug Therapy Cost-benefit Analysis Ferric Compounds / Therapeutic Use Disaccharides / Economics
Online Access:	http://www.ncbi.nlm.nih.gov/books/NBK564173
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa